FDA inspection
Betta Pharmaceuticals Co., Ltd. Site C: FDA inspection ending Nov 13, 2025
FDA inspection 1293932 · Voluntary Action Indicated (VAI) · Hangzhou
Key facts
| Inspection ID | 1293932 |
|---|---|
| Firm | Betta Pharmaceuticals Co., Ltd. Site C |
| FEI number | 3015430059 |
| Address | Linping Economic, No. 24 Wuzhou Road; Yuhang District |
| City | Hangzhou |
| Country | China |
| Fiscal year | 2026 |
| Inspection end date | Nov 13, 2025 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data